Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Assessment of Ozonated Sunflower Seed Oil Gel as an Adjunctive Therapy to Mechanical Debridement in the Treatment of Stage II Grade B Periodontitis

7. juni 2026 oppdatert av: Ahmed Hashem Ahmed Alshareef, Mansoura University

Assessment of Ozonated Sunflower Seed Oil Gel as an Adjunctive Therapy to Mechanical Debridement in the Treatment of Stage II Grade B Periodontitis (Clinical and Laboratory Study)

I) Patients:

The present study will be carried on periodontitis patients. The patients will be informed about the treatment steps. This includes the possible effects or risks, and other treatment options according to the rules of the Ethical Committee of Faculty of dentistry, Mansoura University.

Groups:

Group I (negative control): 15 periodontally healthy subjects. Group II (positive control): 15 patients will be treated with mechanical debridement only.

Group III (study group A): 15 patients will be treated with mechanical debridement followed by delivery of sunflower seed oil gel for each pocket. (J MAC BOTANICALS, organic cold pressed helianthus annuus sunflower seed oil, Waterglider LLC. Spokane Valley, WA 99216, USA).

Group IV (study group B): 15 patients will be treated with mechanical debridement followed by delivery of ozonated sunflower seed oil gel for each pocket.( PurO3, Ozonated Sunflower Oil combines organic sunflower oil and ozone, giving you an oxygen-rich, soothing gel with high amounts of ozone, 1220 S Happy Hollow Rd Fayetteville, AR 72701, USA).

Periodontal evaluation will be performed for all patients at baseline and after three months including the following parameters:

  • Plaque index (PI).(15)
  • Gingival index.(16)
  • Probing pocket depth (PPD).(17)
  • Clinical attachment level (CAL).(18) B) Gingival crevicular fluid sampling. C) Local drug delivery Adequate amount of prepared ozonated sunflower and sunflower oil gel will be delivered into the selected periodontal pockets.

B) Immunological analysis of TNF-α in GCF

Studieoversikt

Detaljert beskrivelse

I) Patients:

The present study will be carried on periodontitis patients. The patient will be selected from Out Patient Clinic, Department of Oral Medicine, Periodontology, Diagnosis and Oral Radiology, Faculty of Dentistry, Mansoura University. The patients will be informed about the treatment steps. This includes the possible effects or risks, and other treatment options according to the rules of the Ethical Committee of Faculty of dentistry, Mansoura University. The patients must be legally competent to provide written consent before performing any required steps.

A)Inclusion Criteria

  1. Patients with Stage II Periodontitis grade B periodontitis (horizontal bone loss with maximum probing depth ≤ 5 mm and with 3-4 mm clinical attachment loss).
  2. Minimum of 20 remaining teeth.
  3. Age range (25 - 50) years.
  4. Good compliance with the plaque control instructions following initial therapy.
  5. Availability for follow up and maintenance program. B) Exclusion Criteria

1. Systemic diseases / drugs which could influence the outcome of the therapy (According to Cornell Medical Index-Health Questionnaire).

2. Receiving periodontal therapy in past 6 month. 3. Pregnant and lactating females. 4. Vulnerable groups of patients (e.g handicapped patients and decisionally impaired individuals).

5. Smoking.

D) Groups:

Group I (negative control): 15 periodontally healthy subjects. Group II (positive control): 15 patients will be treated with mechanical debridement only.

Group III (study group A): 15 patients will be treated with mechanical debridement followed by delivery of sunflower seed oil gel for each pocket. (J MAC BOTANICALS, organic cold pressed helianthus annuus sunflower seed oil, Waterglider LLC. Spokane Valley, WA 99216, USA).

Group IV (study group B): 15 patients will be treated with mechanical debridement followed by delivery of ozonated sunflower seed oil gel for each pocket.( PurO3, Ozonated Sunflower Oil combines organic sunflower oil and ozone, giving you an oxygen-rich, soothing gel with high amounts of ozone, 1220 S Happy Hollow Rd Fayetteville, AR 72701, USA).

II) Clinical Procedures:

  • Medical and dental histories will be taken from patients.
  • Mechanical debridement will be performed using suitable ultrasonic and hand instruments for positive control and study groups.

A) Periodontal assessment:

Periodontal evaluation will be performed for all patients at baseline and after three months including the following parameters:

  • Plaque index (PI).(15)
  • Gingival index.(16)
  • Probing pocket depth (PPD).(17)
  • Clinical attachment level (CAL).(18)

B) Gingival crevicular fluid sampling. The GCF samples will be collected from all subjects at baseline and three months after treatment.(19)

C) Local drug delivery Adequate amount of prepared ozonated sunflower and sunflower oil gel will be delivered into the selected periodontal pockets.

III) Laboratory procedures

A) Pharmaceutics Section: Formulation development:

  1. Sunflower oil and derevatives:

    The study will involve using sunflower oil as pure form and/or ozonated using controlled conditions. The oils will be used in preparation of gel formulation for applications in the mouth cavity using different formulation techniques.

  2. Development of Formulations:

Based on the oil formulation, various gels will be developed with a focus on creating formulations suitable for clinical application.

  • Different gel bases will be evaluated to optimize their physicochemical characteristics.
  • Physicochemical Parameters of the gel formulations will be assessed to ensure the desired properties.
  • The developed gels will undergo in-vitro testing under different conditions.
  • Once optimized, the selected gel formulation(s) will be prepared for testing in clinical trials.

B) Immunological analysis of TNF-α in GCF

Assessment of crevicular fluid TNF-α will be performed using enzyme-linked immunosorbent assay technique

Studietype

Intervensjonell

Registrering (Faktiske)

60

Fase

  • Tidlig fase 1

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Al Mansurah, Egypt
        • Mansoura University, faculty of dentistry

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen

Tar imot friske frivillige

Ja

Beskrivelse

Inclusion Criteria:

  1. Patients with Stage II Periodontitis grade B periodontitis (horizontal bone loss with maximum probing depth ≤ 5 mm and with 3-4 mm clinical attachment loss).
  2. Minimum of 20 remaining teeth.
  3. Age range (25 - 50) years.
  4. Good compliance with the plaque control instructions following initial therapy.
  5. Availability for follow up and maintenance program.

Exclusion Criteria:

  1. Systemic diseases / drugs which could influence the outcome of the therapy (According to Cornell Medical Index-Health Questionnaire).
  2. Receiving periodontal therapy in past 6 month.
  3. Pregnant and lactating females.
  4. Vulnerable groups of patients (e.g handicapped patients and decisionally impaired individuals).
  5. Smoking.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Annen: positive control group
control recived mechanical debridment only
mechanical debridment
Ingen inngripen: negative control
healthy
Eksperimentell: study group A
sunflower seed oil gel for each pocket
patients will be treated with mechanical debridement followed by delivery of sunflower seed oil gel for each pocket
Eksperimentell: study group B
Ozonated Sunflower Oil
patients will be treated with mechanical debridement followed by delivery of ozonated sunflower seed oil gel for each pocket

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
assess the clinical effectiveness of the locally delivered ozonated sunflower seed oil as an adjunctive therapy to mechanical debridement in stage II grade B periodontitis
Tidsramme: 3 month
1) Plaque Index: deposits were recorded the level of oral hygiene.The percentage of all tooth surfaces that showed the presence of plaque was determined by recording the full-mouth plaque score dichotomously (presence/absence of plaque) on six different points per tooth.The frequency of positive surfaces was given in percentages relative to the total number of tested surfaces. 2) Gingival index: 0 = Normal gingiva.1=Slight inflammation.2 = Moderate glazing. 3 = Severe. 3) Probing pocket depth:For each group, the PPD was measured from the base of the pocket on the whole mouth to the free gingival margin.4) Clinical attachment level:It is the space between the base of the periodontal pocket and CEJ. Six locations were used to measure the clinical attachment loss: three on the facial surface and three on the lingual or palatal surface.5) Bleeding on probing:take the percentage from all teeth that appear BOP
3 month

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
assess the impact of the locally delivered ozonated sunflower seed oil as an adjunctive therapy to mechanical debridement on the GCF level of TNF-α in stage II periodontitis
Tidsramme: 3 months
GCF sample will be assessed for TNF-α. TNF-α. is an inflammatory mediator. Assessment of gingival crevicular fluid(GCF) TNF-α will be performed using enzyme-linked immunosorbent assay technique.
3 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Ahmed Hashem Alshareef, Bachelors degree, Mansoura University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

7. mars 2025

Primær fullføring (Faktiske)

25. mars 2026

Studiet fullført (Faktiske)

30. april 2026

Datoer for studieregistrering

Først innsendt

30. mai 2026

Først innsendt som oppfylte QC-kriteriene

7. juni 2026

Først lagt ut (Faktiske)

9. juni 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

9. juni 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

7. juni 2026

Sist bekreftet

1. mars 2025

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • M04020250M

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere